Showing results (61-70 of 600) with videos related to
Sort By:
Pageof 60
Trends in Pharmacological Sciences|September 24, 2004
Techniques: species' finest blend--humanized mouse models in inflammatory skin disease researchFrederik H Igney, Khusru Asadullah, Thomas M ZollnerDrug Discovery Today|December 14, 2011
What makes a good drug target?Isabella Gashaw, Peter Ellinghaus, Anette Sommer, et al.The Indian Journal of Medical Research|February 8, 2023
Exploratory analysis of the suitability of data from the civil registration system for estimating excess mortality due to COVID-19 in Faridabad district of IndiaAyon Gupta, Md Asadullah, Rakesh Kumar, et al.Experimental Dermatology|December 22, 2006
Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach?Thomas M Zollner, Khusru Asadullah, Michael P SchönJournal of the College of Physicians and Surgeons--Pakistan : JCPSP|July 12, 2007
Intensive care management after inadvertent intravascular injection of liquid paraffinWaqas Ahmed Kazi, Rashad Siddiqi, Syed Asadullah JafriMolecular and Cellular Endocrinology|July 17, 2007
Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic indexHeike Schäcke, Markus Berger, Hartmut Rehwinkel, et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP|February 10, 2010
Coronary anomalies in Pakistani children with tetralogy of FallotIjaz Hussain, Najma Patel, Abdul Ghaffar, et al.European Cytokine Network|June 9, 2005
Cytokines as potential therapeutic targets for inflammatory skin diseasesRobert P Numerof, Charles A Dinarello, Khusru AsadullahExperimental Dermatology|May 13, 2006
Glucocorticoid therapy-induced skin atrophyStefanie Schoepe, Heike Schäcke, Ekkehard May, et al.Expert Opinion on Drug Discovery|March 20, 2013
Humanised mouse models in drug discovery for skin inflammationFrederik H Igney, Khusru Asadullah, Thomas M ZollnerPageof 60